A New Paradigm in Radiation Oncology

Over the past 30 years, conventional IGRT has introduced many life saving developments, yet poor soft tissue contrast, the use of surrogates to identify anatomy, and having no real-time imaging during beam-on have often constrained clinical potential.

Combining the latest innovations in precision radiation delivery with groundbreaking MR image guidance and on-table adaptive therapy, it’s time for the next big advance in radiation oncology.

The future of radiation therapy is here.

First pioneered by ViewRay in 2012, MRI-Guided ROAR™ represents a new paradigm in the treatment of cancer, providing clinicians with the ability to improve targeting precision and thus deliver higher, and potentially more effective, radiation doses.

Watch Video

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Cookie Policy

RSS Webinar: The Role of MRgRT in Prostate Cancer

Thu, Jun 24, 2021 10:00 AM – 11:00 AM MDT

To describe the role of MRI in prostate cancer diagnosis and treatment
To discuss the evolution of imaging for prostate cancer in radiation treatment
To discuss the paradigm shift to ultra-hypofractionation for prostate cancer
To gain insight into the setup and delivery of a MR-guided SABR program for prostate cancer
To understand the context for re-irradiation of the prostate after primary radiotherapy.
To review the practicalities of a re-irradiation program.

Presenters:

Himanshu Nagar, MD, Weill Cornell Medicine

Phillip Camilleri, MD Genesiscare UK

Moderated By: Amar Kishan, MD, UCLA

Click here to register

Join ViewRay - Executive Customer Roundtable

Delivering Strategic and Economic Value with MRI-Guided Radiation Therapy

Join us for this unique opportunity to learn how MRI-guided radiation therapy programs can deliver clinical benefit and how that can translate into strategic and economic value, based on a given center’s practice environment. Hear executive leadership, from two renowned institutions, share their insights into the decision-making factors that led to the investment in MRI-guided radiotherapy. Describing their experience, these executives will share the value MRI-guided radiotherapy brings to their cancer programs. They will discuss the clinical value to their patient care and how this unique technology has changed the types of cancers they treat and how it has added incremental benefits to their overall cancer care.

When: Thursday, June 24, 2021 · 09:00:00 AM · Mountain Time (US & Canada)

Click here to register

MRI-Guided ROAR^™

Real-Time On-Table Adaptive Radiotherapy

A New Paradigm in Radiation Oncology

The future of radiation therapy is here.

First pioneered by ViewRay in 2012, MRI-Guided ROAR™ represents a new paradigm in the treatment of cancer, providing clinicians with the ability to improve targeting precision and thus deliver higher, and potentially more effective, radiation doses.

Global Info

MRI-Guided ROAR™

Real-Time On-Table Adaptive Radiotherapy

A New Paradigm in Radiation Oncology

The future of radiation therapy is here.

First pioneered by ViewRay in 2012, MRI-Guided ROAR™ represents a new paradigm in the treatment of cancer, providing clinicians with the ability to improve targeting precision and thus deliver higher, and potentially more effective, radiation doses.

Global Info

CUSTOMER LOGIN

MRI-Guided ROAR^™